Evaluation of the effectiveness of zinc supplementation in children with urinary tract infectio
Phase 2
- Conditions
- rinary tract infection.Urinary tract infection, site not specified
- Registration Number
- IRCT138903094056N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Female children 3 to 12 years old with UTI, without norogenic bladder, anatomical abnormalities, or any other malformations or kidney stones
Exclusion criteria: Lack of patient cooperation, inappropriate use of prescribed drugs, history of recurrent UTI, those who have been treated for their UTI with drugs other than Ceftriaxon and Cefoxim
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary Tract Infection. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Dysuria. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.;Abdominal pain. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child.;Fever. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Thermometer.;Frequency. Timepoint: 14 days after treatment (Daily 14 days) - 7 to 10 days after the end of treatment ( Urine Culture). Method of measurement: Asking mother and child - Results of urine tests.
- Secondary Outcome Measures
Name Time Method Anorexia. Timepoint: 14 days after treatment. Method of measurement: Mother and child statement.;Growth failure. Timepoint: 6 months after treatment. Method of measurement: Mother's remarks.;Weight loss. Timepoint: Three month after treatment. Method of measurement: Mother's remarks.